Centercon Pharmaceutical Private Limited
About Centercon Pharmaceutical Private Limited
Data last updated:
Centercon Pharmaceutical Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24297MH2010PTC205473. Its GSTIN is 27AAECC0651L1ZO (Maharashtra).
The company has an authorised share capital of ₹1.1 Lakh and a paid-up capital of ₹1.07 Lakh. It is led by directors Pramod Manoharrao Suple and Anil Janardanpant Sonar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sarvadaya H. No. 2016 Parsodi Near Shri Nagar Gayatri Nagar Road, Nagpur, Maharashtra, India – 440022.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.45 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹4.48 Lakh (net margin 3.1%) and EBITDA of ₹8.41 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.
As per MCA filings, the company has satisfied charges of ₹15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Centercon Pharmaceutical Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSarvadaya H. No. 2016 Parsodi Near Shri Nagar Gayatri Nagar Road, Nagpur, Maharashtra, India – 440022
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Centercon Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Centercon Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Centercon Pharmaceutical Private Limited, buy the company report.
Financials of Centercon Pharmaceutical Private Limited
FY 2024 filings availableCentercon Pharmaceutical Private Limited reported revenue of ₹1.45 Cr (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Centercon Pharmaceutical Private Limited, buy the company report.
Board of directors of Centercon Pharmaceutical Private Limited
Centercon Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Manoharrao Suple | Director | 08 Mar 2013 | 13 Years 7 Months | Current |
| Anil Janardanpant Sonar | Director | 14 Jul 2010 | 16 Years 3 Months | Current |
Peer comparison
Centercon Pharmaceutical Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sainum Medisciences Private Limited | ₹1.45 Cr (FY 2025) | 13.0% | Basti, Uttar Pradesh, India | |||
| Zenfochem Private Limited | ₹1.45 Cr (FY 2025) | 128.0% | Hyderabad, Telangana, India | |||
| Insightra Medical Private Limited | ₹1.45 Cr (FY 2024) | 383.0% | Mumbai, Maharashtra, India | |||
| Centercon Pharmaceutical Private Limitedthis company | ₹1.45 Cr (FY 2025) | ₹4.48 Lakh | 3.1% | -5.0% | Nagpur, Maharashtra, India | |
| Aivee Labs Private Limited | ₹1.45 Cr (FY 2025) | 52.0% | Hyderabad, Telangana, India | |||
| Univen Healthcare Private Limited | ₹1.45 Cr (FY 2025) | -27.0% | Chennai, Tamil Nadu, India | |||
| Care U Pharma Private Limited | ₹1.45 Cr (FY 2024) | -25.0% | Chennai, Tamil Nadu, India | |||
| Zenvista Meditech Private Limited | ₹1.45 Cr (FY 2025) | -2.0% | Rudrapur, Uttarakhand, India |
To see the full peer comparison of Centercon Pharmaceutical Private Limited, buy the company report.
Auditor
Centercon Pharmaceutical Private Limited is audited by Suhas M Charde & co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suhas M Charde & co. | FY 2024 | 144327W |
Shareholding
The shareholding of Centercon Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Centercon Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2011 | 10286577 | Bank of India | ₹15 Lakh | Satisfied |
To see the full charge records of Centercon Pharmaceutical Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Centercon Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Centercon Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Centercon Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECC0651L1ZO | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Centercon Pharmaceutical Private Limited, buy the company report.
Recent activity
Centercon Pharmaceutical Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Prasad Phasate ceased to be Director on 20 Mar 2013.
Frequently asked questions
Centercon Pharmaceutical is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 July 2010 (16+ years old) and is registered under CIN U24297MH2010PTC205473.
Centercon Pharmaceutical has 2 current directors:
- Pramod Manoharrao Suple - Director
- Anil Janardanpant Sonar - Director
The latest financial statements of Centercon Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Centercon Pharmaceutical is 27AAECC0651L1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Centercon Pharmaceutical is U24297MH2010PTC205473. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Centercon Pharmaceutical was incorporated on 14 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Centercon Pharmaceutical by revenue are Sainum Medisciences Private Limited, Zenfochem Private Limited, Insightra Medical Private Limited, Aivee Labs Private Limited, Univen Healthcare Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Prasad Phasate ceased to be Director on 20 Mar 2013. Pramod Manoharrao Suple was appointed as Director on 08 Mar 2013. Anil Janardanpant Sonar was appointed as Director on 14 Jul 2010.
The registered office of Centercon Pharmaceutical is at Sarvadaya H. No. 2016 Parsodi Near Shri Nagar Gayatri Nagar Road, Nagpur, Maharashtra, India – 440022.
Centercon Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Centercon Pharmaceutical has no open charges and satisfied charges of ₹15 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
